2,6-Dichloro-4-(trifluoromethyl)phenylhydrazine

We are 2,6-Dichloro-4-(trifluoromethyl)phenylhydrazine CAS:86398-94-9 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

CAS No: 86398-94-9
Product Name: 2,6-Dichloro-4-(trifluoromethyl)phenylhydrazine
Other Name:
2,6-Dichloro-4-(trifluoromethyl)phenylhydrazine
1-[2,6-Dichloro-4-(trifluoromethyl)phenyl]hydrazine
 
Density: 1.6±0.1 g/cm3
Boiling Point: 223.9±40.0 °C at 760 mmHg
Melting Point: 58-60 °C(lit.)
Molecular Formula: C7H5Cl2F3N2
Molecular Weight: 245.029
Flash Point: 89.2±27.3 °C
Exact Mass: 243.978195
PSA: 38.05000
LogP: 3.68
Vapour Pressure: 0.1±0.4 mmHg at 25°C
Index of Refraction: 1.559
 
Specification
Appearance: Colorless solid
Loss on drying: ≤2.0%
Heavy metals: ≤10 ppm
Water: ≤1.0%
Sulphated ash: ≤0.5%
Single impurity: ≤0.10%
Total Impurity: ≤0.5%
Purity: ≥99.0%
Assay: 99.0%~101.0%
 
Application
Intermediates of Fipronil CAS: 120068-37-3.
Be used as pesticide intermediate.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

2,6-Dichloro-4-(trifluoromethyl)phenylhydrazine


Related News: International Chemical Investors Group (ICIG) recently announced it has entered into a purchase agreement under which an affiliate of ICIG will acquire the pharmaceutical intermediates business from Genzyme Corporation.4-nitroheptanedial International Chemical Investors Group (ICIG) recently announced it has entered into a purchase agreement under which an affiliate of ICIG will acquire the pharmaceutical intermediates business from Genzyme Corporation.593-58-8 Inceptua is a pharmaceutical company and service partner spanning throughout the product lifecycle – from comparator sourcing for clinical trials, through early access programs to licensing and commercialization for products.2-Bromocarbazole CAS:3652-90-2 China will use its national drug bulk-buy scheme to lower the price of drugs currently sold at higher prices compared with other markets, it said in an official statement.Rigosertib is a small molecule that inhibits cellular signaling in cancer cells by acting as a RAS mimetic. Current clinical development of rigosertib is centered upon the therapeutic management of MDS, a heterogeneous group of bone marrow disorders characterized by ineffective hematopoiesis that often develop into acute myeloid leukaemia (AML).

Related Products
Product Name
3-Isopropoxyaniline View Details
4-[4-(dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl]-3-(hydroxymethyl)benzonitrile,hydrochloride View Details
2-(1-Naphthalenyloxy)propanoic acid View Details
4-fluorobutyl acetate manufacturer DL-Homocysteine manufacturer 6-chloro-7H-purine manufacturer Methyl [(dimethoxyphosphinothioyl)thio]acetate manufacturer 2-(2-(2,2,2-Trifluoroethoxy)phenoxy)ethyl methanesulfonate manufacturer